| 000 | 01865 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513143040.0 | ||
| 264 | 0 | _c19980812 | |
| 008 | 199808s 0 0 eng d | ||
| 022 | _a0940-5437 | ||
| 024 | 7 |
_a10.1007/s005990050012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarone, G | |
| 245 | 0 | 0 |
_aImmunopharmacology of human mast cells and basophils. _h[electronic resource] |
| 260 |
_bInternational journal of clinical & laboratory research _c1998 |
||
| 300 |
_a12-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAdenylyl Cyclases _xmetabolism |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 |
_aBasophils _xdrug effects |
| 650 | 0 | 4 | _aCD40 Ligand |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGlucocorticoids _xpharmacology |
| 650 | 0 | 4 |
_aHistamine Release _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInflammation |
| 650 | 0 | 4 |
_aMast Cells _xdrug effects |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xphysiology |
| 650 | 0 | 4 | _aOrgan Specificity |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSteroids |
| 650 | 0 | 4 |
_aTacrolimus _xpharmacology |
| 700 | 1 | _aSpadaro, G | |
| 700 | 1 | _aDe Marino, V | |
| 700 | 1 | _aAliperta, M | |
| 700 | 1 | _aTriggiani, M | |
| 773 | 0 |
_tInternational journal of clinical & laboratory research _gvol. 28 _gno. 1 _gp. 12-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s005990050012 _zAvailable from publisher's website |
| 999 |
_c9561105 _d9561105 |
||